254 related articles for article (PubMed ID: 34067609)
1. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.
Barh D; Aljabali AA; Tambuwala MM; Tiwari S; Serrano-Aroca Á; Alzahrani KJ; Silva Andrade B; Azevedo V; Ganguly NK; Lundstrom K
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067609
[TBL] [Abstract][Full Text] [Related]
2. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.
Barh D; Tiwari S; Andrade BS; Weener ME; Góes-Neto A; Azevedo V; Ghosh P; Blum K; Ganguly NK
Mol Omics; 2021 Apr; 17(2):317-337. PubMed ID: 33683246
[TBL] [Abstract][Full Text] [Related]
3. Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis.
Toppen W; Yan P; Markovic D; Shover CM; Buhr RG; Fulcher JA; Tashkin DP; Barjaktarevic I
Int J Chron Obstruct Pulmon Dis; 2022; 17():3111-3121. PubMed ID: 36570857
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of comorbid diseases in patients after COVID-19.
Kamilova U; Ermekbaeva A; Nuritdinov N; Khamraev A; Zakirova G
J Med Life; 2023 Mar; 16(3):447-450. PubMed ID: 37168295
[TBL] [Abstract][Full Text] [Related]
5. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
6. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
7. Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology.
Aguirre-Plans J; Piñero J; Menche J; Sanz F; Furlong LI; Schmidt HHHW; Oliva B; Guney E
Pharmaceuticals (Basel); 2018 Jun; 11(3):. PubMed ID: 29932108
[TBL] [Abstract][Full Text] [Related]
8. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
[TBL] [Abstract][Full Text] [Related]
9. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19.
Zheng W; Wang T; Wu P; Yan Q; Liu C; Wu H; Zhan S; Liu X; Jiang Y; Zhuang H
Front Pharmacol; 2021; 12():718874. PubMed ID: 35002688
[No Abstract] [Full Text] [Related]
10. Characterization and Validation of ceRNA-Mediated Pathway-Pathway Crosstalk Networks Across Eight Major Cardiovascular Diseases.
Song C; Zhang J; Liu Y; Hu Y; Feng C; Shi P; Zhang Y; Wang L; Xie Y; Zhang M; Zhao X; Cao Y; Li C; Sun H
Front Cell Dev Biol; 2022; 10():762129. PubMed ID: 35433687
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
12. Topological network based drug repurposing for coronavirus 2019.
Habibi M; Taheri G
PLoS One; 2021; 16(7):e0255270. PubMed ID: 34324563
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
[TBL] [Abstract][Full Text] [Related]
14. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
Front Immunol; 2023; 14():961642. PubMed ID: 37026010
[TBL] [Abstract][Full Text] [Related]
15. Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(22):1-23. PubMed ID: 23074527
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
17. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
18. Establishment of comorbidity target pools and prediction of drugs candidate for multiple sclerosis and autoimmune thyroid diseases based on GWAS and transcriptome data.
Wang X; Wang Y; Zhang X; Hong X; Rang X; Yang D; Huang S; Xu C; Fu J
Mult Scler Relat Disord; 2023 Oct; 78():104903. PubMed ID: 37556937
[TBL] [Abstract][Full Text] [Related]
19. Molecular crosstalk between COVID-19 and Alzheimer's disease using microarray and RNA-seq datasets: A system biology approach.
Premkumar T; Sajitha Lulu S
Front Med (Lausanne); 2023; 10():1151046. PubMed ID: 37359008
[TBL] [Abstract][Full Text] [Related]
20. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
